App-Based diets show promise for IBS relief

NCT ID NCT07607132

Completed Symptom relief Sponsor: Sahlgrenska University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether a digital platform offering two carbohydrate-reduced diets (low FODMAP or low-carb) could help adults with irritable bowel syndrome (IBS). 32 participants used the app for four weeks, reporting their symptoms and quality of life. The goal was to see if this digital approach is effective and practical for symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital dietary platform with low FODMAP or low-carbohydrate diet
What this could lead to: If successful, this could provide a convenient, scalable way for people with IBS to manage their symptoms through diet without needing a dietitian.
What could go wrong: This is a small pilot study with only 32 participants and no control group, so results may not be reliable or apply to everyone. The diets may not work for all IBS patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRRITABLE BOWEL SYNDROME

Contacts and locations

Locations

Dept of Internal Medicine, Sahlgrenska University Hospital

Gothenburg, 41345, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.